Conditions Articles
Latest articles, insights, and updates from the blog.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.
Ketamine-Assisted Therapy for Substance Use Disorders: Clinical Trials Review
Review of ketamine-assisted therapy for substance use disorders including alcohol, cocaine, and opioid dependence — examining clinical trials, neuroplasticity mechanisms, and outcomes.
Low-Dose Ketamine for Social Anxiety Disorder: Preliminary Evidence
Examining preliminary evidence for low-dose ketamine in social anxiety disorder, including glutamatergic mechanisms, neuroimaging findings, and early-phase clinical data.
Ketamine for OCD: Glutamatergic Modulation of Obsessive-Compulsive Circuits
Review of ketamine in OCD treatment, examining glutamatergic modulation of cortico-striato-thalamo-cortical circuits, clinical trial evidence, and rapid anti-obsessional effects.
Low-Dose Ketamine for Bipolar Depression: Efficacy and Safety Data
Comprehensive review of low-dose ketamine for bipolar depression, examining clinical trial efficacy, safety profiles, and rapid-acting antidepressant mechanisms in bipolar disorder.
Low-Dose Ketamine for Anxiety Disorders
A clinical overview of subanesthetic ketamine's therapeutic potential in generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder, including mechanistic pathways, current evidence, and considerations for clinical practice.
Ketamine-Assisted Therapy for PTSD and Trauma
Is ketamine being used for PTSD and cPTSD? A clinical look at low-dose ketamine-assisted psychotherapy, neurobiological rationale, and current trial evidence.
Low-Dose Ketamine for Chronic Pain Syndromes
A clinical review of subanesthetic ketamine infusion therapy for chronic pain conditions including complex regional pain syndrome, fibromyalgia, and neuropathic pain, covering mechanisms, protocols, and evidence.
Low-Dose Ketamine for Treatment-Resistant Depression
An evidence-based overview of low-dose ketamine as a rapidly acting antidepressant for patients with treatment-resistant depression, including mechanisms of action, clinical protocols, and outcome data.